Autopsy report · NCT01000948

A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“A consequence of the results of the ENTHUSE phase III study program”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 9 months before it stopped.
24 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Aarhus University Hospital
Sponsor type: University, hospital or other
Conditions: Prostate Cancer; Metastasis
Interventions: ZD4054
Participants: 24
Sites: 1
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.